Oncology

News

There are three types of white blood cells. T lymphocytes, B lymphocytes and natural killer cells.

Gilead’s Kite gains some height after second CAR-T approval ...

Gilead’s $11.9 billion purchase of Kite Pharma in 2017 didn’t follow the script, with two big write-downs in the value of the asset since then, but a fresh approval for a CAR-T

News

CHMP gives nod to GSK’s BCMA drug Blenrep for myeloma

GlaxoSmithKline is closing in on EU approval for its first-in-class BCMA-targeting drug Blenrep, after getting a green light from the EMA’s human medicines committee.

Views & Analysis

GSK’s John Fleming on rethinking oncology from the ground up

What if we could look at cancer treatment from a completely fresh perspective?

News

Gilead eyes takeover of cancer biotech Tizona, despite its t...

Gilead Sciences’ run of oncology-focused deals has continued with an option to buy cancer immunotherapy specialist Tizona – even though the biotech’s lead drug candidate is alr

Views & Analysis

How to increase haematologists’ and oncologists’ confidence ...

A new whitepaper from Medscape highlights the difficulties haematologists and oncologists face in keeping up with rapid developments in treatment.

Views & Analysis

Clinical decision support tools will help oncologists manage...

Making treatment decisions is a tough choice for oncologists: a therapy might save or significantly extend one patient’s life but not deliver the desired outcome for another patient.

Gilead’s Kite gains some height after second CAR-T approval ...

CHMP gives nod to GSK’s BCMA drug Blenrep for myeloma

GSK’s John Fleming on rethinking oncology from the ground up

Gilead eyes takeover of cancer biotech Tizona, despite its t...

How to increase haematologists’ and oncologists’ confidence ...

Clinical decision support tools will help oncologists manage...

Roche culls myostatin candidate from obesity pipeline

Discover a new era of healthcare panel engagement: Grounded ...

Oncology

Editor's Picks